Christopher M. Yea
2022
In 2022, Christopher M. Yea earned a total compensation of $2.7M as Chief Development Officer at Carbylan Therapeutics, a 90% increase compared to previous year.
Compensation breakdown
| Bonus | $182,000 |
|---|---|
| Option Awards | $1,089,276 |
| Salary | $455,000 |
| Stock Awards | $923,400 |
| Other | $27,279 |
| Total | $2,676,955 |
Yea received $1.1M in option awards, accounting for 41% of the total pay in 2022.
Yea also received $182K in bonus, $455K in salary, $923.4K in stock awards and $27.3K in other compensation.
Rankings
In 2022, Christopher M. Yea's compensation ranked 1,371st out of 5,756 executives tracked by ExecPay. In other words, Yea earned more than 76.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,371 out of 5,756 | 76th |
Division Manufacturing | 678 out of 3,133 | 78th |
Major group Chemicals And Allied Products | 252 out of 1,419 | 82nd |
Industry group Drugs | 231 out of 1,320 | 83rd |
Industry Pharmaceutical Preparations | 164 out of 966 | 83rd |
Source: SEC filing on August 14, 2023.
Yea's colleagues
We found two more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2022.